Evidence map›Paper›PMID 36970569›Full record

ReviewInfluenza and other respiratory viruses2023

A review of policies and coverage of seasonal influenza vaccination programs in the WHO Eastern Mediterranean Region.

Rania Attia, Abdinasir Abubakar, Joseph Bresee, Osama Mere, Wasiq Khan

Open access · goldFull text readReview
In one paragraph

Review in Influenza and other respiratory viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Rania AttiaWHO Regional Office for the Eastern Mediterranean Cairo Egypt.ORCID 0000-0003-1441-6181
Abdinasir AbubakarWHO Regional Office for the Eastern Mediterranean Cairo Egypt.
Joseph BreseeThe Task Force for Global Health Decatur Georgia USA.
Osama MereWHO Regional Office for the Eastern Mediterranean Cairo Egypt.
Wasiq KhanWHO Regional Office for the Eastern Mediterranean Cairo Egypt.
World Health Organization Regional Office for the Eastern Mediterranean · EGThe Task Force for Global Health · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Although there has been an effective seasonal influenza vaccine available for more than 60 years, influenza continues to circulate and cause illness. The Eastern Mediterranean Region (EMR) is very diverse in health systems capacities, capabilities, and efficiencies, which affect the performance of services, especially vaccination, including seasonal influenza vaccination. Aims: The aim of this study is to provide a comprehensive overview on country-specific influenza vaccination policies, vaccine delivery, and coverage in EMR. Materials and Methods: We have analyzed data from a regional seasonal influenza survey conducted in 2022, Joint Reporting Form (JRF), and verified their validity by the focal points. We also compared our results with those of the regional seasonal influenza survey conducted in 2016. Results: Fourteen countries (64%) had reported having a national seasonal influenza vaccine policy. About (44%) countries recommended influenza vaccine for all SAGE recommended target groups. Up to 69% of countries reported that COVID-19 had an impact on influenza vaccine supply in the country, with most of them (82%) reporting increases in procurement due to COVID-19. Discussion: The situation of seasonal influenza vaccination in EMR is varied, with some countries having well established programs while others having no policy or program; these variances may be due to resources inequity, political, and socioeconomic dissimilarities. Few countries have reported wide vaccination coverage over time with no clear trend of improvement. Conclusion: We suggest supporting countries to develop a roadmap for influenza vaccine uptake and utilization, assessment of barriers, and burden of influenza, including measuring the economic burden to enhance vaccine acceptance.

Indexed as

COVID-19Influenza, HumanInfluenza VaccinesHealth PolicyHumansImmunization ProgramsMediterranean RegionSeasonsVaccinationWorld Health OrganizationInfluenza VaccinesEMRinfluenzapolicysurveyvaccinationWHO

Identifiers

PMID36970569
PMCPMC10030358
OpenAlexW4353094203

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read70
reference markers read2
identifiers read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.